PD-1/PD-L1, Integrin Antibody
Besufetamig is a bispecific antibody targeting programmed cell death protein 1 (PD-1) and the CD3ε chain. It modulates immune cell activity, exerting both immunosuppressive and antitumor effects. Besufetamig holds promise for cancer research.
Product Specifications
Target
PD-1/PD-L1, Integrin
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Cancer Biology; Immunology & Inflammation, Cell Biology, Immunology & Inflammation, Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC682884-100 1x 100 µL
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
